Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Høgh P[au]:

[Alzheimer's disease]. Høgh P et al. Ugeskr Laeger. (2017)

Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial. Hoffmann K et al. J Alzheimers Dis. (2016)

Effect of aerobic exercise on physical performance in patients with Alzheimer's disease. Sobol NA et al. Alzheimers Dement. (2016)

Search results

Items: 1 to 50 of 68

1.

A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease.

Gjerum L, Frederiksen KS, Henriksen OM, Law I, Anderberg L, Andersen BB, Bjerregaard E, Hejl AM, Høgh P, Hasselbalch SG.

J Neurol Sci. 2019 Dec 24;410:116645. doi: 10.1016/j.jns.2019.116645. [Epub ahead of print]

PMID:
31911283
2.

Hashimoto's encephalopathy: Follow-up data from neuropsychology, lumbar puncture, and FDG-PET.

Lagström RMB, Østerbye NN, Henriksen OM, Høgh P.

Clin Case Rep. 2019 Aug 8;7(9):1750-1753. doi: 10.1002/ccr3.2367. eCollection 2019 Sep.

3.

Oscillatory connectivity as a diagnostic marker of dementia due to Alzheimer's disease.

Musaeus CS, Engedal K, Høgh P, Jelic V, Mørup M, Naik M, Oeksengaard AR, Snaedal J, Wahlund LO, Waldemar G, Andersen BB.

Clin Neurophysiol. 2019 Oct;130(10):1889-1899. doi: 10.1016/j.clinph.2019.07.016. Epub 2019 Jul 29.

PMID:
31408790
4.

Brief Assessment of Impaired Cognition (BASIC)-Validation of a new dementia case-finding instrument integrating cognitive assessment with patient and informant report.

Jørgensen K, Nielsen TR, Nielsen A, Waldorff FB, Høgh P, Jakobsen S, Gottrup H, Vestergaard K, Waldemar G.

Int J Geriatr Psychiatry. 2019 Nov;34(11):1724-1733. doi: 10.1002/gps.5188. Epub 2019 Aug 19.

5.

Microstates as Disease and Progression Markers in Patients With Mild Cognitive Impairment.

Musaeus CS, Nielsen MS, Høgh P.

Front Neurosci. 2019 Jun 11;13:563. doi: 10.3389/fnins.2019.00563. eCollection 2019.

6.

Moderate- to high-intensity exercise does not modify cortical β-amyloid in Alzheimer's disease.

Frederiksen KS, Madsen K, Andersen BB, Beyer N, Garde E, Høgh P, Waldemar G, Hasselbalch SG, Law I.

Alzheimers Dement (N Y). 2019 Jun 7;5:208-215. doi: 10.1016/j.trci.2019.04.006. eCollection 2019.

7.

A Novel Eight Octapeptide Repeat Insertion in PRNP Causing Prion Disease in a Danish Family.

Areškevičiūtė A, Høgh P, Bartoletti-Stella A, Melchior LC, Nielsen PR, Parchi P, Capellari S, Broholm H, Scheie D, Lund EL.

J Neuropathol Exp Neurol. 2019 Jul 1;78(7):595-604. doi: 10.1093/jnen/nlz037.

PMID:
31107536
8.

Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise.

Jensen CS, Simonsen AH, Siersma V, Beyer N, Frederiksen KS, Gottrup H, Hoffman K, Høgh P, Frikke-Schmidt R, Sobol NA, Waldemar G, Wermuth L, Hasselbalch SG.

Alzheimers Dement (N Y). 2019 Apr 8;5:99-106. doi: 10.1016/j.trci.2019.02.007. eCollection 2019.

9.

Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma.

Jensen CS, Bahl JM, Østergaard LB, Høgh P, Wermuth L, Heslegrave A, Zetterberg H, Heegaard NHH, Hasselbalch SG, Simonsen AH.

Exp Gerontol. 2019 Jul 1;121:91-98. doi: 10.1016/j.exger.2019.04.003. Epub 2019 Apr 11.

10.

Altered Low-Frequency EEG Connectivity in Mild Cognitive Impairment as a Sign of Clinical Progression.

Musaeus CS, Nielsen MS, Høgh P.

J Alzheimers Dis. 2019;68(3):947-960. doi: 10.3233/JAD-181081.

PMID:
30883355
11.

Quantitative Electroencephalography Analyzed by Statistical Pattern Recognition as a Diagnostic and Prognostic Tool in Mild Cognitive Impairment: Results from a Nordic Multicenter Cohort Study.

Schjønning Nielsen M, Simonsen AH, Siersma V, Engedal K, Jelic V, Andersen BB, Naik M, Hasselbalch SG, Høgh P.

Dement Geriatr Cogn Dis Extra. 2018 Nov 27;8(3):426-438. doi: 10.1159/000490788. eCollection 2018 Sep-Dec.

12.

A 16-Week Aerobic Exercise Intervention Does Not Affect Hippocampal Volume and Cortical Thickness in Mild to Moderate Alzheimer's Disease.

Frederiksen KS, Larsen CT, Hasselbalch SG, Christensen AN, Høgh P, Wermuth L, Andersen BB, Siebner HR, Garde E.

Front Aging Neurosci. 2018 Sep 25;10:293. doi: 10.3389/fnagi.2018.00293. eCollection 2018.

13.

Decreased Parietal Beta Power as a Sign of Disease Progression in Patients with Mild Cognitive Impairment.

Musaeus CS, Nielsen MS, Østerbye NN, Høgh P.

J Alzheimers Dis. 2018;65(2):475-487. doi: 10.3233/JAD-180384.

PMID:
30056426
14.

Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease.

Sobol NA, Dall CH, Høgh P, Hoffmann K, Frederiksen KS, Vogel A, Siersma V, Waldemar G, Hasselbalch SG, Beyer N.

J Alzheimers Dis. 2018;65(1):137-145. doi: 10.3233/JAD-180253.

15.

EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer's Disease.

Musaeus CS, Engedal K, Høgh P, Jelic V, Mørup M, Naik M, Oeksengaard AR, Snaedal J, Wahlund LO, Waldemar G, Andersen BB.

J Alzheimers Dis. 2018;64(4):1359-1371. doi: 10.3233/JAD-180300.

PMID:
29991135
16.

The process of disclosing a diagnosis of dementia and mild cognitive impairment: A national survey of specialist physicians in Denmark.

Nielsen TR, Svensson BH, Rohr G, Gottrup H, Vestergaard K, Høgh P, Waldemar G.

Dementia (London). 2018 Jan 1:1471301218777443. doi: 10.1177/1471301218777443. [Epub ahead of print]

PMID:
29806491
17.

Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.

Wolk DA, Sadowsky C, Safirstein B, Rinne JO, Duara R, Perry R, Agronin M, Gamez J, Shi J, Ivanoiu A, Minthon L, Walker Z, Hasselbalch S, Holmes C, Sabbagh M, Albert M, Fleisher A, Loughlin P, Triau E, Frey K, Høgh P, Bozoki A, Bullock R, Salmon E, Farrar G, Buckley CJ, Zanette M, Sherwin PF, Cherubini A, Inglis F.

JAMA Neurol. 2018 Sep 1;75(9):1114-1123. doi: 10.1001/jamaneurol.2018.0894.

18.

Progressive DNA and RNA damage from oxidation after aneurysmal subarachnoid haemorrhage in humans.

Jorgensen A, Staalsoe JM, Simonsen AH, Hasselbalch SG, Høgh P, Weimann A, Poulsen HE, Olsen NV.

Free Radic Res. 2018 Jan;52(1):51-56. doi: 10.1080/10715762.2017.1407413. Epub 2017 Dec 5.

PMID:
29157018
19.

Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease.

Jensen CS, Portelius E, Høgh P, Wermuth L, Blennow K, Zetterberg H, Hasselbalch SG, Simonsen AH.

Alzheimers Dement (N Y). 2017 Apr 17;3(2):284-290. doi: 10.1016/j.trci.2017.03.007. eCollection 2017 Jun.

20.

[Alzheimer's disease].

Høgh P.

Ugeskr Laeger. 2017 Mar 20;179(12). pii: V09160686. Review. Danish.

PMID:
28330540
21.

Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting.

Schjønning Nielsen M, Simonsen AH, Siersma V, Hasselbalch SG, Høgh P.

Dement Geriatr Cogn Dis Extra. 2016 Oct 7;6(3):465-476. eCollection 2016 Sep-Dec.

22.

Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease.

Steen Jensen C, Portelius E, Siersma V, Høgh P, Wermuth L, Blennow K, Zetterberg H, Waldemar G, Gregers Hasselbalch S, Hviid Simonsen A.

Dement Geriatr Cogn Disord. 2016;42(3-4):146-158. Epub 2016 Sep 20.

PMID:
27643858
23.

Electroencephalography Is a Good Complement to Currently Established Dementia Biomarkers.

Ferreira D, Jelic V, Cavallin L, Oeksengaard AR, Snaedal J, Høgh P, Andersen BB, Naik M, Engedal K, Westman E, Wahlund LO.

Dement Geriatr Cogn Disord. 2016;42(1-2):80-92. doi: 10.1159/000448394. Epub 2016 Sep 6.

PMID:
27595479
24.

Effect of aerobic exercise on physical performance in patients with Alzheimer's disease.

Sobol NA, Hoffmann K, Frederiksen KS, Vogel A, Vestergaard K, Brændgaard H, Gottrup H, Lolk A, Wermuth L, Jakobsen S, Laugesen L, Gergelyffy R, Høgh P, Bjerregaard E, Siersma V, Andersen BB, Johannsen P, Waldemar G, Hasselbalch SG, Beyer N.

Alzheimers Dement. 2016 Dec;12(12):1207-1215. doi: 10.1016/j.jalz.2016.05.004. Epub 2016 Jun 23.

PMID:
27344641
25.

[Dementia – a ticking time bomb in the health care system – but is there hope?].

Høgh P.

Ugeskr Laeger. 2016 May 30;178(22). pii: V68167. Danish. No abstract available.

PMID:
27238148
26.

Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.

Hoffmann K, Sobol NA, Frederiksen KS, Beyer N, Vogel A, Vestergaard K, Brændgaard H, Gottrup H, Lolk A, Wermuth L, Jacobsen S, Laugesen LP, Gergelyffy RG, Høgh P, Bjerregaard E, Andersen BB, Siersma V, Johannsen P, Cotman CW, Waldemar G, Hasselbalch SG.

J Alzheimers Dis. 2016;50(2):443-53. doi: 10.3233/JAD-150817.

PMID:
26682695
27.

Autonomic Dysfunction in Patients with Mild to Moderate Alzheimer's Disease.

Jensen-Dahm C, Waldemar G, Staehelin Jensen T, Malmqvist L, Moeller MM, Andersen BB, Høgh P, Ballegaard M.

J Alzheimers Dis. 2015;47(3):681-9. doi: 10.3233/JAD-150169.

PMID:
26401703
28.

Associations between physical function, dual-task performance and cognition in patients with mild Alzheimer's disease.

Sobol NA, Hoffmann K, Vogel A, Lolk A, Gottrup H, Høgh P, Hasselbalch SG, Beyer N.

Aging Ment Health. 2016 Nov;20(11):1139-1146. Epub 2015 Jul 10.

PMID:
26161932
29.

Discrepancy between stimulus response and tolerance of pain in Alzheimer disease.

Jensen-Dahm C, Werner MU, Jensen TS, Ballegaard M, Andersen BB, Høgh P, Waldemar G.

Neurology. 2015 Apr 14;84(15):1575-81. doi: 10.1212/WNL.0000000000001465. Epub 2015 Mar 18.

30.

Validation of the Rowland Universal Dementia Assessment Scale for multicultural screening in Danish memory clinics.

Nielsen TR, Andersen BB, Gottrup H, Lützhøft JH, Høgh P, Waldemar G.

Dement Geriatr Cogn Disord. 2013;36(5-6):354-62. doi: 10.1159/000354375. Epub 2013 Sep 10.

PMID:
24022429
31.

APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.

Schilling S, DeStefano AL, Sachdev PS, Choi SH, Mather KA, DeCarli CD, Wen W, Høgh P, Raz N, Au R, Beiser A, Wolf PA, Romero JR, Zhu YC, Lunetta KL, Farrer L, Dufouil C, Kuller LH, Mazoyer B, Seshadri S, Tzourio C, Debette S.

Neurology. 2013 Jul 16;81(3):292-300. doi: 10.1212/WNL.0b013e31829bfda4. Review.

32.

Caregiver burden and psychosocial services in patients with early and late onset Alzheimer's disease.

Grønning H, Kristiansen S, Dyre D, Rahmani A, Gyllenborg J, Høgh P.

Dan Med J. 2013 Jul;60(7):A4649.

PMID:
23809965
33.

Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodies.

Ziebell M, Andersen BB, Pinborg LH, Knudsen GM, Stokholm J, Thomsen G, Karlsborg M, Høgh P, Mørk ML, Hasselbalch SG.

J Nucl Med. 2013 Jul;54(7):1072-6. doi: 10.2967/jnumed.112.114025. Epub 2013 May 1.

34.

Does Alzheimer's disease with early onset progress faster than with late onset? A case-control study of clinical progression and cerebrospinal fluid biomarkers.

Grønning H, Rahmani A, Gyllenborg J, Dessau RB, Høgh P.

Dement Geriatr Cogn Disord. 2012;33(2-3):111-7. doi: 10.1159/000337386. Epub 2012 Apr 12.

PMID:
22508568
35.

Visual rating and ROI-based parametric analysis of rCBF SPECT in patients with mild or questionable dementia: a comparative study.

Høgh P, Teller AS, Hasselbalch S, Waldemar G.

Dement Geriatr Cogn Disord. 2007;24(6):429-33. Epub 2007 Oct 19.

PMID:
17952007
36.

Validity of dementia diagnoses in the Danish hospital registers.

Phung TK, Andersen BB, Høgh P, Kessing LV, Mortensen PB, Waldemar G.

Dement Geriatr Cogn Disord. 2007;24(3):220-8. Epub 2007 Aug 10.

37.

The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities.

Høgh P, Garde E, Mortensen EL, Jørgensen OS, Krabbe K, Waldemar G.

Acta Neurol Scand. 2007 Apr;115(4):248-53.

PMID:
17376122
38.

Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting.

Bech-Azeddine R, Høgh P, Juhler M, Gjerris F, Waldemar G.

J Neurol Neurosurg Psychiatry. 2007 Feb;78(2):157-61. Epub 2006 Sep 29.

39.

APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.

Burwick RM, Ramsay PP, Haines JL, Hauser SL, Oksenberg JR, Pericak-Vance MA, Schmidt S, Compston A, Sawcer S, Cittadella R, Savettieri G, Quattrone A, Polman CH, Uitdehaag BM, Zwemmer JN, Hawkins CP, Ollier WE, Weatherby S, Enzinger C, Fazekas F, Schmidt H, Schmidt R, Hillert J, Masterman T, Hogh P, Niino M, Kikuchi S, Maciel P, Santos M, Rio ME, Kwiecinski H, Zakrzewska-Pniewska B, Evangelou N, Palace J, Barcellos LF.

Neurology. 2006 May 9;66(9):1373-83.

PMID:
16682670
40.

Temporal lobe hypoperfusion in isolated amnesia with slow onset: a single photon emission computer tomography study.

Høgh P, Madsen Sjö N, Gade A, Waldemar G.

Dement Geriatr Cogn Disord. 2004;18(1):15-23. Epub 2004 Apr 6.

PMID:
15084789
41.

Diagnostic profile of young and middle-aged memory clinic patients.

Vraamark Elberling T, Stokholm J, Høgh P, Waldemar G.

Neurology. 2002 Oct 22;59(8):1259-62.

PMID:
12391361
42.

Potentially reversible conditions in 1000 consecutive memory clinic patients.

Hejl A, Høgh P, Waldemar G.

J Neurol Neurosurg Psychiatry. 2002 Oct;73(4):390-4.

43.

Cerebral blood flow and cognitive dysfunction after coronary surgery.

Abildstrom H, Høgh P, Sperling B, Moller JT, Yndgaard S, Rasmussen LS.

Ann Thorac Surg. 2002 Apr;73(4):1174-8; discussion 1178-9.

PMID:
11996259
44.

Epilepsy presenting as AD: neuroimaging, electroclinical features, and response to treatment.

Høgh P, Smith SJ, Scahill RI, Chan D, Harvey RJ, Fox NC, Rossor MN.

Neurology. 2002 Jan 22;58(2):298-301.

PMID:
11805262
45.

Idiopathic normal-pressure hydrocephalus: evaluation and findings in a multidisciplinary memory clinic.

Bech-Azeddine R, Waldemar G, Knudsen GM, Høgh P, Bruhn P, Wildschiødtz G, Gjerris F, Paulson OB, Juhler M.

Eur J Neurol. 2001 Nov;8(6):601-11.

PMID:
11784345
46.
47.

Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.

Høgh P, Knudsen GM, Kjaer KH, Jørgensen OS, Paulson OB, Waldemar G.

J Geriatr Psychiatry Neurol. 2001 Spring;14(1):42-51.

PMID:
11281316
48.

Regional cerebral blood flow during hyperventilation in patients with acute bacterial meningitis.

Møller K, Høgh P, Larsen FS, Strauss GI, Skinhøj P, Sperling BK, Knudsen GM.

Clin Physiol. 2000 Sep;20(5):399-410.

PMID:
10971552
49.

Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate.

Høgh P, Oturai A, Schreiber K, Blinkenberg M, Jørgensen OS, Ryder L, Paulson OB, Sørensen PS, Knudsen GM.

Mult Scler. 2000 Aug;6(4):226-30.

PMID:
10962542
50.

Regional cerebral blood flow during mechanical hyperventilation in patients with fulminant hepatic failure.

Strauss GI, Høgh P, Møller K, Knudsen GM, Hansen BA, Larsen FS.

Hepatology. 1999 Dec;30(6):1368-73.

PMID:
10573513

Supplemental Content

Support Center